{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:16Z","timestamp":1787027056443,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Lack of adherence to Oral antineoplastic agents (OAAs) treatment has important clinical, social and economic consequences.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To develop and validate a novel instrument for assessing adherence to OAAs, based on the reported experiences of people with cancer in relation to their treatment and the opinions of the healthcare professionals who care for them.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We performed a multicenter validation study of a scale designed to assess adherence to OAAs. First, a steering committee developed the items for an initial scale, based on the results of a qualitative study that evaluated patients\u2019 and professionals\u2019 experiences with this treatment. We then assessed the validity and reliability of the initial scale in a sample of 268 outpatients with cancer who received their OAAs from four Spanish hospitals.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The mean age of the sample of 268 outpatients was 64.1 (standard deviation [SD] 12.4) years, and 47% of participants were women. With the results of this analysis, we developed the EXPAD-ANEO scale, which has 2 factors, one for beliefs and expectations and another for behavior. Both factors explain 52% of the explained common variance. Good reliability was obtained, with a McDonald\u2019s omega of 0.7 for the first factor and 0.6 for the second factor. The fit indices were optimal (Root Mean Square Error of Approximation = 0.02, Comparative Fit Index = 0.99, Tucker Lexis Index = 0.99 and Standardized Root Mean Squared Residual = 0.03), which verifies the appropriateness of the items to the model. We measured EXPAD-ANEO criterion validity against pill count, obtaining a specificity of 80%. We measured convergent validity with the Morisky-Green test and found a significant association (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001). We measured divergent validity with questions on health literacy from the 16-item European Health Literacy Survey and found no correlation (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.153).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    EXPAD-ANEO is the first validated instrument for evaluating patients\u2019 experiences with and adherence to OAAs, providing valuable information that can help health professionals to establish individual strategies or collective programs for improving therapeutic results and reducing healthcare costs.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1113898","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:30:35Z","timestamp":1678321835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of a scale to assess adherence to oral chemotherapy based on the experiences of patients and healthcare professionals (EXPAD-ANEO)"],"prefix":"10.3389","volume":"14","author":[{"given":"Amparo","family":"Talens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"L\u00d3pez-Pintor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Guilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Cant\u00f3-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Lumbreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/JNR.0000000000000101","article-title":"Development and psychometric testing of the Turkish-version oral chemotherapy adherence scale","volume":"23","author":"Bagcivan","year":"2015","journal-title":"J. Nurs. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bulcan.2016.01.010","article-title":"Validation d\u2019un questionnaire mesurant l\u2019adh\u00e9rence et les comp\u00e9tences de gestion des effets secondaires chez des patients trait\u00e9s par cap\u00e9citabine","volume":"103","author":"Baudot","year":"2016","journal-title":"Bull. Du. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1177\/1078155219831377","article-title":"The role of the pharmacist in improving medication beliefs and adherence in cancer patients","volume":"25","author":"Birand","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","article-title":"Best practices for developing and validating scales for health, social, and behavioral research: A primer","volume":"6","author":"Boateng","year":"2018","journal-title":"Front. Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1634\/theoncologist.6-suppl_4-12","article-title":"Answering patients\u2019 needs: Oral alternatives to intravenous therapy","volume":"6","author":"Borner","year":"2001","journal-title":"Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22237\/jmasm\/1430453580","article-title":"Comparison of model fit indices used in structural equation modeling under multivariate normality","volume":"14","author":"Cangur","year":"2015","journal-title":"J. Mod. Appl. Stat. Methods"},{"key":"B7","unstructured":"Standards and guidelines for validation practices: Development and evaluation of measurement instruments\n            ChanE. K. H.\n          2014"},{"key":"B43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4081\/oncol.2019.402","article-title":"Adherence to oral pharmacological treatment in cancer patients: Systematic review","volume":"13","author":"Claros","year":"2019","journal-title":"Oncol Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1590\/s0104-11692010000300002","article-title":"Adaptation and validation of an oral anticoagulation measurement of treatment adherence instrument","volume":"18","author":"Da Silva Carvalho","year":"2010","journal-title":"Rev Lat Am Enfermagem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2466\/pr0.2002.91.3.865","article-title":"Reliability and factor structure of the Brazilian version of the center for epidemiologic studies-depression","volume":"91","author":"da Silveira","year":"2002","journal-title":"Psychol. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/phar.1174","article-title":"Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia","volume":"33","author":"Daouphars","year":"2013","journal-title":"Pharmacotherapy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bjop.12046","article-title":"From alpha to omega: A practical solution to the pervasive problem of internal consistency estimation","volume":"105","author":"Dunn","year":"2014","journal-title":"Br. J. Psychol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.7399\/fh.2017.41.2.10596","article-title":"Adherence and safety study in patients on treatment with capecitabine","volume":"41","author":"Fern\u00e1ndez-Ribeiro","year":"2017","journal-title":"Farm. Hosp."},{"key":"B12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.7417\/CT.2022.2441","article-title":"Adherence to endocrine therapy in women with breast cancer: Development and preliminary validation of the A-BET questionnaire","volume":"173","author":"Gambalunga","year":"2022","journal-title":"Clin. Ter."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2146\/ajhp160475","article-title":"Impact of clinical pharmacists in outpatient oncology practices: A review","volume":"74","author":"Gatwood","year":"2017","journal-title":"Am. J. health-system Pharm. AJHP official J. Am. Soc. Health-System Pharm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7399\/fh.10961","article-title":"Patient-centered prescription model to improve therapeutic adherence in patients with multimorbidity","volume":"42","author":"Gonz\u00e1lez-Bueno","year":"2018","journal-title":"Farm. Hosp."},{"key":"B15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1634\/theoncologist.2015-0405","article-title":"A systematic review of adherence to oral antineoplastic therapies","volume":"21","author":"Greer","year":"2016","journal-title":"Oncol."},{"key":"B16","volume-title":"Multivariate data analysis","author":"Hair","year":"2009"},{"key":"B17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/14737140.2016.1159515","article-title":"Medication adherence to oral anticancer drugs: Systematic review","volume":"16","author":"Huang","year":"2016","journal-title":"Expert Rev. anticancer Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1188\/15.S1.CJON.6-30","article-title":"Factors influencing oral adherence: Qualitative metasummary and triangulation with quantitative evidence","volume":"19","author":"Irwin","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"key":"B19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1590\/0104-1169.0222.2638","article-title":"Validation of the Adherence Determinants Questionnaire scale among women with breast and cervical cancer","volume":"23","author":"Lessa","year":"2015","journal-title":"Rev. Latinoam. Enferm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5964\/meth.7185","article-title":"Msa: The forgotten index for identifying inappropriate items before computing exploratory item factor analysis","volume":"17","author":"Lorenzo-Seva","year":"2021","journal-title":"Methodology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/hex.13366","article-title":"Development and validation in Ecuador of the epd questionnaire, a diabetes-specific patient-reported experience and outcome measure: A mixed-methods study","volume":"25","author":"Martin-Delgado","year":"2021","journal-title":"Health Expect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cali.2013.07.004","article-title":"Conferencia de consenso sobre informaci\u00f3n de eventos adversos a pacientes y familiares","volume":"28","author":"Mart\u00edn-Delgado","year":"2013","journal-title":"Rev. Calid. Asist."},{"key":"B23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/phar.1399","article-title":"Improving adherence to oral cancer therapy in clinical practice","volume":"34","author":"McCue","year":"2014","journal-title":"Pharmacotherapy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/1078155217708022","article-title":"Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents","volume":"24","author":"Middendorff","year":"2018","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: An international delphi study","volume":"19","author":"Mokkink","year":"2010","journal-title":"Qual. Life Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J. Clin. Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med. care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11205-018-1950-z","article-title":"Reliability, population classification and weighting in multidimensional poverty measurement: A Monte Carlo study","volume":"142","author":"N\u00e1jera Catal\u00e1n","year":"2019","journal-title":"Soc. Indic. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","article-title":"Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: The ADAGIO study","volume":"113","author":"Noens","year":"2009","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.gaceta.2018.08.006","article-title":"Health literacy: Psychometric behaviour of the HLS-EU-Q16 questionnaire","volume":"34","author":"Nolasco","year":"2020","journal-title":"Gac. Sanit."},{"key":"B31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7399\/fh.2014.38.6.8061","article-title":"Adherence to oral antineoplastic therapy","volume":"38","author":"Olivera-Fernandez","year":"2014","journal-title":"Farm. Hosp."},{"key":"B32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4067\/s0717-95022017000100037","article-title":"T\u00e9cnicas de Muestreo sobre una Poblaci\u00f3n a Estudio","volume":"35","author":"Otzen","year":"2017","journal-title":"Int. J. Morphol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.japh.2020.12.005","article-title":"Pharmacist-led collaborative medication management programs for oral antineoplastic therapies: A systematic literature review","volume":"61","author":"Passey","year":"2021","journal-title":"J. Am. Pharm. Assoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12885-020-07404-0","article-title":"Development and validation of oral chemotherapy self-management scale","volume":"20","author":"Peng","year":"2020","journal-title":"BMC Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"107815522211126","DOI":"10.1177\/10781552221112603","article-title":"Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments","volume":"16","author":"Signorelli","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"651523","DOI":"10.3389\/fphar.2021.651523","article-title":"Validation of an instrument for measuring adherence to treatment with immunomodulators in patients with multiple myeloma","volume":"12","author":"Silveira","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4321\/s0212-71992007000300009","article-title":"Instrumentos de medida de adherencia al tratamiento","volume":"24","author":"Sol\u00e1n","year":"2007","journal-title":"An. Med. Interna"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.3390\/ijerph18084266","article-title":"Medication experience and adherence to oral chemotherapy: A qualitative study of patients\u2019 and health professionals\u2019 perspectives","volume":"18","author":"Talens","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/0284186X.2013.844353","article-title":"Adherence and patients\u2019 experiences with the use of oral anticancer agents","volume":"53","author":"Timmers","year":"2014","journal-title":"Acta Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.11144\/javeriana.upsy11-2.veef","article-title":"Validaci\u00f3n de una escala para evaluar factores vinculados a la adherencia terap\u00e9utica en pacientes oncol\u00f3gicos","volume":"11","author":"Urzua","year":"2010","journal-title":"Univ. Psychol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11136-008-9396-4","article-title":"Patient reported outcome measures: A model-based classification system for research and clinical practice","volume":"17","author":"Valderas","year":"2008","journal-title":"Qual. Life Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1113898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:30:45Z","timestamp":1678321845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1113898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":43,"alternative-id":["10.3389\/fphar.2023.1113898"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1113898","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"article-number":"1113898"}}